Questions about this study?
The HopeStage team will email you.
Active Not RecruitingNCT04175041
A Dose-Response Study of the Cognitive and Physiological Effects of tDCS to the DLPFC
Device studyAges 18–55United StatesADHD
Understand this study
Who could participate?
Listed age limits: 18 years to 55 years.
- Listed locations
- Boston, United StatesSee all locations and recruitment
- Activities
- Device procedures described in the protocol
- Compensation
- Payment and expense reimbursement have not been verified.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: July 9, 2019
- Recruitment status
- Active Not Recruiting
- Enrollment listed in the registry
- 104
- Sponsor
- Massachusetts General Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Device
- Intervention type
- DEVICE
- Study phase
- Not clearly listed
- Locations
- United States
- Age range
- From 18 Years to 55 Years
- Official registry ID
- NCT04175041
- Official title
Show the full official title
A Dose-Response Study of the Cognitive and Physiological Effects of tDCS to the DLPFC
Recruitment & locations
Not recruitingBoston
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is Massachusetts General Hospital, a hospital or academic medical center.
Who can participate?
Listed age limits: 18 years to 55 years.
Is this study still recruiting?
The registry lists this study as active, but no longer recruiting.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me